Market icon

Which vaccines will RFK end recommendations for?

$1,346,364 Vol.

OUTCOME
% CHANCE

Rules

This market will resolve to "Yes" if the CDC has completely ended its recommendation for the listed vaccine, meaning it no longer recommends it for any category of individuals by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”.

A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution.

The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
Volume
$1,346,364
End Date
Dec 31, 2025
Created At
Feb 22, 2025, 12:10 AM UTC
shield

Beware of external links.

$1,346,364 Vol.

Market icon

Which vaccines will RFK end recommendations for?

OUTCOME
% CHANCE

Influenza

$22,750 Vol.

3%

Polio

$12,484 Vol.

2%

Hepatitis B

$161,413 Vol.

2%

COVID-19

$580,663 Vol.

1%

HPV

$310,350 Vol.

1%

Measles Mumps and Rubella

$258,705 Vol.

1%

About

Volume
$1,346,364
End Date
Dec 31, 2025
Created At
Feb 22, 2025, 12:10 AM UTC
shield

Beware of external links.